Progesterone increases the expression of myelin basic protein and the number of cells showing NG2 immunostaining in the lesioned spinal cord

Journal of Neurotrauma

Volumn 23, Issue 2, 2006, Pages 181-192

  Labombarda, Florencia ^a   Gonzalez, Susana ^a   Deniselle, Maria Claudia Gonzalez ^a   Garay, Laura ^a   Guennoun, Rachida ^b   Schumacher, Michael ^b   De Nicola, Alejandro F ^a,c  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b BICÊTRE HOSPITAL   (France)

^c INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

Author keywords

Myelin basic protein; Neuroprotection; NG2+ cells; Oligodendrocytes; Progesterone; Spinal cord injury

Indexed keywords

ANTIBODY; CELL MARKER; MESSENGER RNA; MYELIN BASIC PROTEIN; PROGESTERONE; PROTEOCHONDROITIN SULFATE; PROTEOGLYCAN NG2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; CELL PROLIFERATION; CONTROLLED STUDY; DEMYELINATION; GRAY MATTER; IMMUNOHISTOCHEMISTRY; LUMBAR SPINAL CORD; MALE; MOTONEURON; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PROTEIN EXPRESSION; PYRAMIDAL TRACT; RAT; SPINAL CORD INJURY; STEM CELL; THORACIC SPINAL CORD; WHITE MATTER;

ANIMALS; ANTIGENS; CELL COUNT; MALE; MYELIN BASIC PROTEINS; OLIGODENDROGLIA; PROGESTERONE; PROTEOGLYCANS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SPINAL CORD INJURIES; STEM CELLS;

EID: 33644912082     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2006.23.181     Document Type: Article

References (50)

1. AZCOITIA, I., LEONELLI, E., MAGNAGHI, V., VEIGA, S., GARCIA SEGURA, L.M., AND MELCANGI, R. (2003). Progesterone and its derivatives dihydroprogesterone and tetrahydroprogesterone reduce myelin fiber morphological abnormalities and myelin fiber loss in the sciatic nerve of aged rats. Neurobiol. Aging 24, 853-860.
2. BEATTIE, M.S., FAROOQUI, A.A. and BRESNAHAN, J.E. (2000). Review of current evidence for apoptosis after spinal cord injury. J. Neurotrauma 17, 915-923.
3. BLIGHT, A.R. (1985). Delayed demyelination and macrophage invasion: a candidate for secondary cell damage in spinal cord injury. Centr. Nerv. Syst. Trauma 2, 299-315.
4. BRESNAHAN, J.C. (1978). An electron microscopic analysis of axonal alterations following blunt contusion of the spinal cord of the rhesus monkey (Macaca mulatta). J. Neurol. Sci. 37, 59-82.
5. BUNGE, R.P., PUCKETT, W.R., BECERRA, J.L., MARCILLO, A., and QUENCER, R.M. (1993). Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Adv. Neurol. 59, 75-89.
6. CARROL, W.M., JENNINGS, A.R., and IRONSIDE, L.J. (1998). Identification of the adult resting progenitor cell by autoradiographic tracking of oligodendrocyte precursors in experimental CNS demyelination. Brain 121, 293-302.
7. CHAN, J.R., PHILLIPS, L.J., and GLASER, M. (1998). Glucocorticoids and progestins signal the initiation and enhance the rate of myelin formation. Proc. Natl. Acad. Sci. USA 95, 10459-10464.
8. CHAN, J.R., COSGAYA, J.M., WU, Y.J., and SHOOTER, E.M. (2001). Neurotrophins are key mediators of the myelination program in the peripheral nervous system. Proc. Natl. Acad. Sci. USA 98, 14661-14668.
9. CIRIZA, I., AZCOITIA, I., and GARCIA-SEGURA, L.M. (2004). Reduced progesterone metabolites protect rat hippocampal neurones from kainic acid excitotoxicity in vivo. J. Neuroendocrinol. 16, 58-63.
10. DESARNAUD, F., DO THI, A.N., BROWN, A.M., et al. (1998). Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells. J. Neurochem. 71, 1765-1768.
11. DJEBAILI, M., GUO, Q., PETTUS, E.H., HUFFMAN, S.W., and STEIN, D.G. (2005). The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury. J. Neurotrauma 22, 106-118.
12. DOUGHERTY, K.D., DREYFUS, C., and BLACK, I.B. (2000). Brain-derived neurotrophic factor in astrocytes, oligodendrocytes, and microglia/macrophages after spinal cord injury. Neurobiol. Dis. 7, 574-585.
13. DU, Y., FISCHER, T.Z., LEE, L.N., LERCHER, L.D., and DREYFUS, C.F. (2003). Regionally specific effects of BDNF on oligodendrocytes. Dev. Neurosci. 25, 116-128.
14. FERRINI, M., LIMA, A., and DE NICOLA, A.F. (1995). Estradiol abolishes autologous down-regulation of glucocorticoid receptors in brain. Life Sci. 57, 2403-2412.
15. FOURNIER, A.E., and STRIITTMATTRER, S.M. (2001). Repulsive factors and axon regeneration in the CNS. Curr. Opin. Neurobiol. 11, 89-94.
16. GAGO, N., EL-ETR, M., SANANES, N., et al. (2004). 3α,5α- Tetrahydroprogesterone (allopregnanolone) and γ-aminobutyric acid: autocrine/paracrine interactions in the control of neonatal PSA-NCAM+ progenitor proliferation. J. Neurosci. Res. 78, 770-783.
17. GHOUMARI, A.M., BAULIEU, E.E., and SCHUMACHER, M. (2005). Progesterone increases oligodendroglial cell proliferation in rat cerebellar slice cultures. Neurosci. 135, 47-58.
18. GHOUMARI, A.M., IBANEZ, C., EL-ETR, M., et al. (2003). Progesterone and its metabolites increase myelination in organotypic slice cultures of rat cerebellum. J. Neurochem. 86, 848-859.
19. GONZÁLEZ, S.L., LABOMBARDA, F., GONZÁLEZ DENISELLE, M.C., GUENNOUN, R., SCHUMACHER, M., and DE NICOLA, A.F. (2004). Progesterone up-regulates neuronal brain-derived neurotrophic factor expression in the injured spinal cord. Neuroscience 125, 605-614.
20. GONZALEZ DENISELLE, M.C., LOPEZ COSTA, J.J., PECCI SAAVEDRA, J., et al. (2002). Progesterone neuroprotection in the Wobbler mouse, a genetic model of spinal cord motor neuron disease. Neurobiol. Dis. 11, 457-468.
21. GREENWOOD, K., and BUTT, A.M. (2003). Evidence that perinatal and adult NG2-glia are not conventional oligodendrocyte progenitors and do not depend on axons for their survival. Mol. Cell. Neurosci. 23, 544-558.
22. GUENNOUN, R., BENMESSAHEL, Y., DELESPIERRE, B., et al. (2001). Progesterone stimulates Krox-20 gene expression in Schwann cells. Mol. Brain Res. 90, 75-82.
23. HUBBARD, P. (2003). The response of novel NG2 glia to spinal cord injury. Spinal Res. 1, 100-107.
24. IBANEZ, C., SHIELDS, S.A., LIERE, P., et al. (2004). Systemic progesterone administration results in a partial reversal of the age-associated decline in CNS remyelination following toxin-induced demyelination in male rats. Neuropathol. Appl. Neurobiol. 30, 80-89.
25. ISHII, K., TODA, M., NAKAI, Y., et al. (2001). Increase of oligodendrocyte progenitor cells after spinal cord injury. J. Neurosci. Res. 65, 500-507.
26. JONES, L.L., YAMAGUCHI, Y., STALLCUP, W.B., and TUSZYNSKI, M.H. (2002). NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J. Neurosci. 22, 2792-2803.
27. JUNG-TESTAS, I., SCHUMACHER, M., ROBEL, P., and BAULIEU, E.E. (1996). The neurosteroid progesterone increases the expression of myelin proteins (MBP and CNPase) in rat oligodendrocytes in primary culture. Cell. Mol. Neurobiol. 16, 439-443.
28. JUNG-TESTAS, I., DO THI, A., KOENIG, H., et al. (1999). Progesterone as a neurosteroid: synthesis and actions in rat glial cells. J. Steroid Biochem. Mol. Biol. 69, 97-107.
29. KEIRSTEAD, H.S., and BLACKEMORE, W.F. (1997). Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord. J. Neuropathol. Exp. Neurol. 56, 1191-1201.
30. KOENIG, H.L., SCHUMACHER, M., FERZAZ, B., et al. (1995). Progesterone synthesis and myelin formation by Schwann cells. Science 268, 1500-1502
31. LABOMBARDA, F., GUENNOUN, R., GONZALEZ, S., et al. (2000). Immunocytochemical evidence for a progesterone receptor in neurons and glial cells of the rat spinal cord. Neurosci. Lett. 288, 29-32.
32. LABOMBARDA, F., GONZALEZ, S., GONZALEZ DENISELLE, M.C., GUENNOUN, R., SCHUMACHER, M., and DE NICOLA, A.F. (2002). Cellular basis for progesterone neuroprotection in the injured spinal cord. J. Neurotrauma 19, 343-355.
33. LABOMBARDA, F., GONZÁLEZ, S.L., GONZALEZ DENISELLE, M.C., et al. (2003). Effects of injury and progesterone treatment on progesterone receptor and progesterone binding protein 25-DX expression in the rat spinal cord. J. Neurochem. 87, 902-913.
34. LEVINE, J.M., REYNOLDS, R., and FAWCETT, J.W. (2001). The oligodendrocyte precursor cell in health and disease. Trends Neurosci. 24, 39-47.
35. LI, G., and BLAKEMORE, W.F. (2004). The number of cells expressing the myelin-supporting oligodendrocyte marker PLP-exon 3b remains unchanged in Wallerian degeneration. J. Neurotrauma 21, 1044-1049.
36. McTIGUE, D.M., HORNER, P.J., STOKES, B.T., and GAGE, F.H. (1998). Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J. Neurosci. 15, 5354-5365.
37. McTIGUE, D.M., WEI, P., and STOKES, B.T. (2001). Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused spinal cord. J. Neurosci. 21, 3392-3400.
38. MELCANGI, R.C., MAGNAGHI, V., and MARTINI, L. (2000). Aging in peripheral nerves: regulation of myelin protein genes by steroid hormones. Prog. Neurobiol. 60, 291-308.
39. NGUYEN, K.B., and PENDER, M.P. (1999). Survival and mitosis of myelinating oligodendrocytes in experimental autoimmune encephalomyelitis: an immunocytochemical study with Rip antibody. Acta Neuropathol. (Berl.) 98, 39-47.
40. NISHIYAMA, A., CHANG, A., and TRAPP, B.D. (1999). NG2+ glial cells: a novel glial cell population in the adult brain. J. Neuropathol. Exp. Neurol. 58, 1113-1124.
41. PAXINOS, G., and WATSON, C. (1983). The Rat Brain in Stereotaxic Coordinates. Academic Press: New York.
42. ROOF, R., DUVDEVANI, R., and BRASWELL, L. (1994). Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp. Neurol. 129, 64-69
43. SCHUMACHER, M., AKWA, I., GUENNOUN, R., et al. (2000). Steroid synthesis and metabolism in the nervous system: trophic and protective effects. J. Neurocytol. 29, 307-326.
44. SIM, F.J., HINKS, G.L., and FRANKLIN, R.J. (2000). The re-expression of the homeodomain transcription factor Gtx during remyelination of experimentally induced demyelinating lesions in young and old rat brain. Neuroscience 100, 131-139.
45. STEIN, D.G., and FULOP, Z.L. (1998). Progesterone and recovery after traumatic brain injury: an overview. Neuroscientist 4, 435-442.
46. TANAKA, K., NOGAWA, S., SUZUKI, S., DEMBO, T., and KOSAKI, A. (2003). Upregulation of oligodendrocyte progenitor cells associated with restoration of mature oligodendrocytes and myelination in peri-infart area in the rat brain. Brain Res. 989, 172-179.
47. THOMAS, A., NOCKELS, R., PAN, H., SHAFFREY, C., and CHOPP, M. (1999). Progesterone is neuroprotective after acute experimental spinal cord trauma in rats. Spine 24, 2134-2138.
48. TOLWANI, R.J., COSYAGA, J.M., VARMA, S., JACOB, R., KUO, L.E., and SHOOTER, E.M. (2004). BDNF overexpression produces a long-term increase in myelin formation in the peripheral nervous system. J. Neurosci. Res. 77, 662-669.
49. VERDI, J.M., and CAMPAGNONI, A.T. (1990). Translational regulation by steroids. Identification of a steroid modulatory element in the 5′-untranslated region of the myelin basic protein messenger RNA. J. Biol. Chem. 265, 20314-20320.
50. YE, P., BAGNELL, R., and D'ERCOLE, A.J. (2003) Mouse NG2+ oligodendrocyte precursors express mRNA for proteolipid protein but not its DM-20 variant: a study of laser microdissection-captured NG2+ cells. J. Neurosci. 23, 4401-4405.